UK markets closed

Shield Therapeutics plc (STX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
2.0500-0.0250 (-1.20%)
At close: 04:04PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13,085
13,085
5,499
2,050
14,156
Cost of revenue
9,058
9,058
3,041
1,323
1,845
Gross profit
4,027
4,027
2,458
727.4543
12,310
Operating expenses
Research development
1,810
1,810
1,320
1,072
3,515
Selling general and administrative
36,889
36,889
30,773
24,217
8,045
Total operating expenses
35,358
35,358
34,104
28,117
15,246
Operating income or loss
-31,331
-31,331
-31,646
-27,390
-2,936
Interest expense
1,016
1,016
403
0
0
Income before tax
-32,375
-32,375
-49,343
-26,867
-2,570
Income tax expense
918
918
446
-309.0669
1,014
Income from continuing operations
-33,293
-33,293
-49,789
-26,558
-3,584
Net income
-33,293
-33,293
-49,789
-26,558
-3,584
Net income available to common shareholders
-33,293
-33,293
-49,789
-26,558
-3,584
Basic EPS
-0.12
-0.05
-0.21
-0.12
-0.03
Diluted EPS
-0.12
-0.05
-0.21
-0.12
-0.03
Basic average shares
476,634
665,860
237,906
221,163
120,682
Diluted average shares
476,634
665,860
237,906
221,163
120,682